Skip to content

13F-HR filed by Kalehua Capital Management LLC

Kalehua Capital Management LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 17:28:35 UTC, with 22 holding rows worth $132,396,155.

Accession
0002106181-26-000010
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 22 entries on the cover page, a total value of $132,396,155 stated on the cover page (in dollars after the unit check, H1), rows summing to $132,396,155 with VALUE read as dollars as filed, 13F file number 028-26381. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VERADERMICS INC922967104COMMON STOCK145,695$17,662,605dollars as filed
EA SERIES TRUST02072L565ALPHA ARCH 1-3148,471$17,577,482dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK442,653$14,164,896dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK3,722,840$10,796,236dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock1,832,365$9,638,240dollars as filed
SURROZEN INC86889P208COMMON STOCK286,092$9,206,441dollars as filed
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK3,821,890$7,853,984dollars as filed
SEPTERNA INC COM81734D104Stock194,544$7,612,507dollars as filed
Betterlife Pharma Inc F08772P202COM27,710,000$6,675,339dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share416,649$5,720,591dollars as filed
Inflarx NvN44821101COM2,921,095$5,257,971dollars as filed
KORRO BIO INC500946108COMMON STOCK473,595$4,693,326dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM200,000$3,428,000dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK139,000$2,957,920dollars as filed
UNIQURE NVN90064101SHS79,407$1,918,473dollars as filed
Gossamer Bio, Inc.38341P201Common Stock, $0.0001 par value per share139,366$1,651,487dollars as filed
Milestone Pharmaceuticals Inc59935V107COM1,651,258$1,429,494dollars as filed
LeonaBio Inc04746L203COM393,701$1,405,513dollars as filed
ATRIUM THERAPEUTICS INC COM04965N104Stock112,652$932,759dollars as filed
Instil Bio Inc45783C200COM NEW99,600$721,104dollars as filed
ATYR PHARMA INC002120202COM NEW1,829,513$554,342dollars as filed
KAZIA THERAPEUTICS LTD48669G303SPONSORED ADS56,013$537,445dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002106181-26-000010this filing2026-11-13